# Plain Language Summary: Stopping the Mutilation of Children Act of 2024

This bill would cut off federal funding to any hospital, clinic, or medical provider that offers gender-affirming medical or surgical treatments. Specifically, it prohibits federal money from going to any entity that provides these treatments to help someone transition or live in alignment with their gender identity. The bill defines sex strictly in biological terms and carves out an exception for treatments related to developmental or genetic conditions or injuries.

In practical terms, this would affect hospitals and clinics that receive Medicare, Medicaid, or other federal healthcare funding. If they continue offering gender-affirming care—whether that's hormone therapy, puberty blockers, or surgical procedures—they would lose access to all federal dollars. This creates a significant financial pressure since most major medical institutions rely heavily on federal funding. The impact would be felt most acutely by transgender and non-binary people seeking these treatments, particularly young people and those with lower incomes who depend on Medicaid or federally-funded clinics for healthcare.

The bill's scope is broad. It doesn't just restrict treatments for minors; it applies to anyone of any age. It also doesn't distinguish between different types of care—it treats hormone therapy the same as surgery. The exception for "developmental or genetic anomalies or historical accidents" appears designed to allow treatments for intersex conditions or injuries, but the language is vague enough that it could be interpreted different ways.

This is a highly contested policy area. Medical organizations like the American Medical Association support gender-affirming care as appropriate treatment, while others argue the government should restrict it. The bill represents a significant federal intervention into medical practice and would fundamentally reshape how healthcare providers can operate if they want federal funding.